Retrieved from https://studentshare.org/history/1664664-measles-mumps-and-rubella
https://studentshare.org/history/1664664-measles-mumps-and-rubella.
Its vaccine was made and licensed in 1968 (Barone, Crocetti and Oski, 321). (d). Pathogenesis and pathology of Rubella involves measles virus entering the body system, then to the epithelial cells, and finally to the blood where it multiplies (MPS). In blood the virus advances to general toxic level. The general toxic level of the disease is associated with the presentation of rashes, pigmentation as well as koplik’s spots (Shmaefsky, p.83). (e). Clinical manifestations of Rubella appears after an incubation period 6-18 days.
The clinical signs include fever, catarrhal inflammation, koplik’s spots, and appearance prodromal rashes on the skin surface (Shmaefsky, p.85). (d). The pathogenesis and pathology of Ruboela involves measles virus entering the body, then virus moves to the epithelial cells, then to blood where it multiplies (MPS), blood and later generates to general toxic level. When it is at the general level, Ruboela is presents rashes, pigmentation and koplik’s spots (Black, p.90). (e). Clinical manifestation of Ruboela are portrayed after the incubation period of between 6-18 days.
The clinical manifestations include fever, catarrhal inflammation, koplik’s spots on the skin as well as prodromal rashes (Black,
...Download file to see next pages Read More